Schedule 13D ownership disclosure
Supernus Pharmaceuticals Inc
Security class unavailable · CUSIP: 868459108
Event date: 2015-06-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-15-000323
- Form type
- SC 13D
- Filer
- NEW ENTERPRISE ASSOCIATES 11 LP
- CIK
- CIK 1243094
- Filed
- Jun 17, 2015
- Reporting period
- Jun 15, 2015
- Description
- Schedule 13D beneficial ownership